BAFNA PHARMACEUTICALS
Back to Income Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹3.11 | ₹4.79 | ₹2.21 | ₹2.46 | ₹-7.94 |
What is the latest Earnings Per Share (EPS) of BAFNA PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹3.11 |
| Mar2024 | ₹4.79 |
| Mar2023 | ₹2.21 |
| Mar2022 | ₹2.46 |
| Mar2021 | ₹-7.94 |
How is Earnings Per Share (EPS) of BAFNA PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.11 | -35.07 | |
| Mar2024 | ₹4.79 | 116.74 | |
| Mar2023 | ₹2.21 | -10.16 | |
| Mar2022 | ₹2.46 | Positive | |
| Mar2021 | ₹-7.94 | - | |
Compare Earnings Per Share (EPS) of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹574.5 Cr | 5.8% | 34.6% | 216.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 5.8% |
34.6% |
216.9% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses